Cite
HARVARD Citation
Wanner, C. et al. (n.d.). FO022BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON. Nephrology dialysis transplantation. p. i10. [Online].